These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 15904473)

  • 41. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: an overview.
    Ciociola AA; Webb DD; Turner K
    Scand J Gastroenterol Suppl; 1996; 218():3-9. PubMed ID: 8865444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
    Savarino V; Zentilin P; Bisso G; Pivari M; Bilardi C; Biagini R; Mele MR; Mansi C; Termini R; Vigneri S; Celle G
    Aliment Pharmacol Ther; 1999 Jan; 13(1):43-7. PubMed ID: 9892878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.
    Savarino V; Mansi C; Mele MR; Bisso G; Mela GS; Saggioro A; Caroli M; Vigneri S; Termini R; Olivieri A; Tosatto R; Celle G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):699-703. PubMed ID: 9305478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
    Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori.
    Schwartz HI; Perschy TB; McSorley DJ; Sorrells SC
    Helicobacter; 1999 Jun; 4(2):121-7. PubMed ID: 10382126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate.
    Gudjonsson H; Bardhan KD; Hoie O; Kristensen ES; Schuetz E; Kliebe-Frisch C; Pipkin GA; Duggan AE
    Aliment Pharmacol Ther; 1998 Nov; 12(11):1113-9. PubMed ID: 9845401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of a multistep strategy for Helicobacter pylori eradication.
    Gasbarrini A; Ojetti V; Armuzzi A; Branca G; Canducci F; Torre ES; Candelli M; Pastorelli A; Anti M; Fedeli G; Fadda G; Pola P; Gasbarrini G
    Aliment Pharmacol Ther; 2000 Jan; 14(1):79-83. PubMed ID: 10632649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
    Thong-Ngam D; Mahachai V
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S119-25. PubMed ID: 17718277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
    Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
    Spinzi GC; Boni F; Bortoli A; Colombo E; Ballardini G; Venturelli R; Minoli G
    Aliment Pharmacol Ther; 2000 Mar; 14(3):325-30. PubMed ID: 10735926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
    Dobrilla G; Di Matteo G; Dodero M; Fratton A; Iaquinto G; Loriga P; Marchi S; Marzio L; Muratori R; Pacini D; Saggioro A; Savarino V; Spinelli P; Zamboni G; Fina P; Tosatto R; Olivieri A
    Aliment Pharmacol Ther; 1998 Jan; 12(1):63-8. PubMed ID: 9692703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helicobacter pylori and gastric or duodenal ulcer.
    Prescrire Int; 2016 Jan; 25(167):18-23. PubMed ID: 26942258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
    Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
    Perri F; Villani MR; Quitadamo M; Annese V; Niro GA; Andriulli A
    Aliment Pharmacol Ther; 2001 Jul; 15(7):1017-22. PubMed ID: 11421877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
    Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
    Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
    Van der Wouden EJ; Thijs JC; Zwet AA; Kooy A; Kleibeuker JH
    Aliment Pharmacol Ther; 1999 Mar; 13(3):297-302. PubMed ID: 10102961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.